Random C-peptide in the classification of diabetes

Author： Berger B.   Stenström G.   Sundkvist G.  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.60, Iss.8, 2000-12, pp. : 687-693

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

C‐peptide: should we be testing this routinely in the Type 1 diabetes clinic?

By  

DIABETIC MEDICINE, Vol. 742-3071, Iss. 10, 2015-10 ,pp. : 1259-1260

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Short‐Term Effects of C‐Peptide on the Early Diabetes‐Related Ultrastructural Changes to the Podocyte Slit Diaphragm of Glomeruli in Rats

By  

MICROCIRCULATION (ELECTRONIC), Vol. 22, Iss. 2, 2015-02 ,pp. : 122-132

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low levels of C‐peptide have clinical significance for established Type 1 diabetes

By  

DIABETIC MEDICINE, Vol. 742-3071, Iss. 10, 2015-10 ,pp. : 1346-1353

John Wiley & Sons Inc

Access to resources Recommend Favorite

Changes in circulating adiponectin, leptin, glucose and C‐peptide in patients with ketosis‐prone diabetes

By  

DIABETIC MEDICINE, Vol. 32, Iss. 5, 2015-05 ,pp. : 692-700

John Wiley & Sons Inc

Access to resources Recommend Favorite

C-peptide in dried blood spots

By Johansson Jesper   Becker Charlotte   Persson Nils-Göran   Fex Malin   Törn Carina  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 70, Iss. 6, 2010-10 ,pp. : 404-409

Informa Healthcare

Access to resources Recommend Favorite